Results 201 to 210 of about 306,427 (235)

Bepridil in hypertrophic obstructive cardiomyopathy

American Heart Journal, 1987
W, Haerer, D, Weritz, M, Stauch
openaire   +2 more sources

Cardiovascular Disorders and Epigenetics

Medical Epigenetics, 2021
Charbel Abi Khalil
exaly  

Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): Health Status Analysis of a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Lancet, The, 2021
Carolyn Ho, Daniel Jacoby
exaly  

Hypertrophic obstructive cardiomyopathy in the elderly

American Heart Journal, 1973
A J, Tajik, J L, Assad-Morell, E R, Giuliani   +2 more
openaire   +2 more sources

Hypertrophic obstructive cardiomyopathy

American Heart Journal, 1965
openaire   +2 more sources

Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2023
Albree Tower-Rader, Timothy Wong, Caroline J Coats   +2 more
exaly  

Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy

Circulation, 2021
Neal K Lakdawala, Raymond Y Kwong, Andrew Wang   +2 more
exaly  

Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Lancet, The, 2020
Mathew S Maurer, Juan Gimeno Blanes
exaly  

Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology, 2021
Mads Andersen, Torsten B Rasmussen, Steen Hvitfeldt Poulsen   +2 more
exaly  

Aficamten for Obstructive Hypertrophic Cardiomyopathy

New England Journal of Medicine
Jorge, Pedreira-Bouzas, Álvaro, Pousada-Fonseca, Dolores, Fraga   +2 more
openaire   +3 more sources